OCLG — Oncologix Tech Balance Sheet
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.17m
- $3.37m
- $3.68m
Annual balance sheet for Oncologix Tech, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
C2010 August 31st | 2011 August 31st | 2012 August 31st | 2013 August 31st | 2014 August 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.011 | 0.011 | 0.002 | 0.039 | 0.018 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | 0.108 | 0.213 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.017 | 0.015 | 0.005 | 0.218 | 0.275 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.002 | 0 | 0.001 | 0.079 | 0.04 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.019 | 0.015 | 0.006 | 2.03 | 2.14 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 0.253 | 0.662 | 0.234 | 1.58 | 2.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 0.612 | 0.659 | 0.59 | 2.39 | 2.8 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.593 | -0.644 | -0.584 | -0.357 | -0.665 |
Total Liabilities & Shareholders' Equity | 0.019 | 0.015 | 0.006 | 2.03 | 2.14 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |